Educational Program for Preeclampsia

(PrEPS Trial)

Overseen By Alice Sherman-Brown, MD

Age: 18+

Sex: Female

Trial Phase: Academic

Sponsor: MemorialCare Health System

Disqualifiers: Age < 18, Non-English, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

36 Participants Needed

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of this treatment for preeclampsia?

Research shows that when women understand preeclampsia through education, they are more likely to recognize symptoms early and seek treatment, which can lead to better health outcomes. For example, 75% of women who understood their education acted on it, compared to only 6% who did not remember the education. ^{1 2 3 4 5}

How does the Educational Program for Preeclampsia differ from other treatments?

This treatment is unique because it uses an illustration-based and text-based application to educate pregnant women about preeclampsia, helping them recognize symptoms early and manage their condition better. Unlike traditional treatments, this program focuses on improving knowledge and self-care, which can lead to earlier diagnosis and better outcomes. ^{1 3 4 6 7}

What is the purpose of this trial?

Preeclampsia complicates approximately 8% of all pregnancies. A critical factor of outpatient monitoring is patient education; specifically, education regarding nature of the disease, ongoing short- and long-term risks, and warning signs and symptoms for worsening of disease. This study aims to compare patient knowledge using a novel illustration based app compared to standard discharge instructions.

Research Team

Megan Oakes, MD MSCI

Principal Investigator

Magella Medical Group, MemorialCare

Eligibility Criteria

This trial is for pregnant individuals diagnosed with preeclampsia who can read and speak English, receive care from specific clinics, and have consistent access to a mobile device that can scan QR codes and run applications.

Inclusion Criteria

I have been diagnosed with preeclampsia.

I have a smartphone or tablet that can scan QR codes and use apps.

My prenatal and postnatal care is managed by an OB clinic or a maternal-fetal medicine specialist.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week

Intervention

Participants receive education via either an illustration-based app or a text-based app

24 hours

1 visit (in-person)

Short-term Follow-up

Participants' preeclampsia knowledge scores are assessed 24 hours post-intervention

24 hours

Long-term Follow-up

Participants' preeclampsia knowledge scores and other secondary outcomes are assessed between 4 to 6 weeks postpartum

4-6 weeks

Treatment Details

Interventions

• Illustration based application
• Text based application

Trial Overview The study compares two methods of patient education on preeclampsia: one using an illustration-based app and the other using standard discharge instructions. The goal is to see which method improves patient knowledge more effectively.

Participant Groups

Group I: Illustration Experimental Treatment 1 Intervention

This study arm will receive education via an illustration based application

Group II: Text Active Control 1 Intervention

This study arm will receive education via text based application

Who Is Running the Clinical Trial?

MemorialCare Health System

Lead Sponsor

Trials

21

Recruited

2,600+

References

1. England pubmed.ncbi.nlm.nih.gov

Prenatal education is an opportunity for improved outcomes in hypertensive disorders of pregnancy: results from an Internet-based survey. [2013]

2. Netherlands pubmed.ncbi.nlm.nih.gov

Does a patient information sheet lead to better understanding of pre-eclampsia? A randomised controlled trial. [2015]

3. England pubmed.ncbi.nlm.nih.gov

Readability, content, and quality of online patient education materials on preeclampsia. [2016]

4. Ireland pubmed.ncbi.nlm.nih.gov

Improving the knowledge of pregnant women using a pre-eclampsia app: A controlled before and after study. [2019]

5. Netherlands pubmed.ncbi.nlm.nih.gov

Pre-eclampsia Educational Tool Impact on Knowledge, Anxiety, and Satisfaction in Pregnant Women: A Randomized Trial. [2020]

6. Iran pubmed.ncbi.nlm.nih.gov

The Design and Evaluation of a Mobile based Application to Facilitate Self-care for Pregnant Women with Preeclampsia during COVID-19 Prevalence. [2021]

7. England pubmed.ncbi.nlm.nih.gov

Factors associated with patient understanding of preeclampsia. [2014]